Simple calculation eg CEO sold share average RM0 14 Then take up ESOS at RM0.105 Did he make profit? Then push up share price and company Buy back % of share in the company he own will. Increase At the end of the day.. ..siapa untung
I rmb this company boss promise alot of big plan in newspaper few years ago. My advise to you all if wan goreng counter, pls goreng better counter. Dont put hopes in this company. K thanks bye.
ESOS are new shares created when the holder excercise the option by paying the exercise price. So if the option holder want to benefit from it the share price must be high. This company has a warrant with exercise price at RM0.22. If the company hope the warrant holder to exercise the warrant the share price will have to be higher than that.
Number of share will increase after ESOS. But this mean also the management is positive about their company performance and share price..if not it is meanlingless to set up option which require them to put in money into the company. Now the intersting part will be who he sold the shares to by direct interest.
helllooooooo, my top and reliable news....there will be a taking over and i bought 0.105 and 0110 a alot alot alot... who wants to taruk? it will hit 0.20 before the end of the year!!! u thought investors stupid ones???? buying from william Hon for no reason???? go and check William still has warrant ... relax lahhhhh
Funny little fake news, It is margin call laa, apa take over pulak. If take over why still need declare ESOS, logic la. The business still running well, and all pharmacy still operate as usual.
insidertiptip helllooooooo, my top and reliable news....there will be a taking over and i bought 0.105 and 0110 a alot alot alot... who wants to taruk? it will hit 0.20 before the end of the year!!! u thought investors stupid ones???? buying from william Hon for no reason???? go and check William still has warrant ... relax lahhhhh
Incorporated in 2005 and subsequently listed on Bursa Malaysia’s ACE Market a decade later in 2015, BioAlpha is Malaysia’s home-grown biotechnology company, mainly involved in the manufacturing and sale of functional food and health supplement products. We like BioAlpha for its: (i) integrated supply chain, (ii) diversified export markets, (iii) proprietary liquid fermentation technology for medicinal mushrooms, and (iv) experienced in-house R&D team. We value BioAlpha at RM0.25 based on 15x FY20F EPS, ascribing a discount to its peer average given its smallish market capitalization ... Good potential to hv exponential growth after 2020, let it grow ...
Last round, it dropped from 25 cents to below 10 cents was because of margin calls of William's accounts. But fundamental is intact and growth story is there. And with this pandemic, their nutraceutical products and pharmacy retail businesses should be doing well, whereby people emphasis more on building their immune system
New IPO: Building management systems (BMS), solar thermal systems and energy-saving services provider, Solar District Cooling Bhd aims to list on the Ace Market!
MQ Trader 791 views | 5 d ago
0:17
New IPO: The onshore and offshore support services provider for the O&G industry, Steel Hawk Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Abd Rahim Osman
333 posts
Posted by Abd Rahim Osman > 2020-04-18 17:46 | Report Abuse
Dont forget
He got ESOS 50 million at RM0.105
He not leaving the company..
Strategy game